Published in PLoS Pathog on September 19, 2013
The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development. J Exp Med (2015) 1.16
Interactions between innate and adaptive lymphocytes. Nat Rev Immunol (2014) 1.08
Universal immunity to influenza must outwit immune evasion. Front Microbiol (2014) 1.03
Innate lymphoid cells: new insights into function and development. Curr Opin Immunol (2015) 0.92
Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations. J Leukoc Biol (2014) 0.92
Group 2 innate lymphoid cells in health and disease. Cold Spring Harb Perspect Biol (2015) 0.84
Interferon-γ constrains cytokine production of group 2 innate lymphoid cells. Immunology (2015) 0.83
Innate immune sensing and response to influenza. Curr Top Microbiol Immunol (2015) 0.82
Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease. Curr Allergy Asthma Rep (2016) 0.81
Innate lymphocyte cells in asthma phenotypes. Clin Transl Allergy (2015) 0.81
Innate lymphoid cells in asthma: Will they take your breath away? Eur J Immunol (2016) 0.80
Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. J Allergy Clin Immunol (2016) 0.79
Type 2 innate lymphoid cells: at the cross-roads in allergic asthma. Semin Immunopathol (2016) 0.79
Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation. J Immunol Res (2014) 0.79
Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time. Genes Immun (2015) 0.77
Group 2 innate lymphoid cells in the lung. Adv Immunol (2014) 0.76
Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury. J Exp Med (2016) 0.76
IL-21 promotes late activator APC-mediated T follicular helper cell differentiation in experimental pulmonary virus infection. PLoS One (2014) 0.75
Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis. J Immunol Res (2016) 0.75
Expression of SCGB1C1 gene as a potential marker of susceptibility to upper respiratory tract infections in elite athletes - a pilot study. Biol Sport (2016) 0.75
The origin and role of innate lymphoid cells in the lung. Mil Med Res (2016) 0.75
Pleural cavity type 2 innate lymphoid cells precede Th2 expansion in murine Litomosoides sigmodontis infection. Exp Parasitol (2015) 0.75
ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control. J Exp Med (2017) 0.75
STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection. J Immunol (2017) 0.75
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science (1997) 13.67
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature (2010) 10.34
Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature (2009) 9.71
Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol (2013) 7.94
The eosinophil. Annu Rev Immunol (2006) 7.06
Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A (2010) 6.78
Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol (2011) 6.73
Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol (2011) 6.23
Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med (2006) 5.35
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20
The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One (2008) 4.52
Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol (2012) 4.27
Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med (2009) 4.22
Interleukin-5, eosinophils, and disease. Blood (1992) 3.80
The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity (2012) 3.65
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A (2009) 3.39
IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol (2008) 3.09
An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med (2012) 2.60
Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol (2004) 2.50
New paradigms in type 2 immunity. Science (2012) 2.27
Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog (2011) 2.25
Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science (2013) 2.22
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc Natl Acad Sci U S A (2010) 2.22
Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol (2011) 2.12
Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem (2009) 2.00
Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol (2004) 1.92
Cutting edge: Natural helper cells derive from lymphoid progenitors. J Immunol (2011) 1.67
Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation. Gastroenterology (2005) 1.62
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med (2010) 1.61
Allergic airway inflammation is exacerbated during acute influenza infection and correlates with increased allergen presentation and recruitment of allergen-specific T-helper type 2 cells. Clin Exp Allergy (2004) 1.60
Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis (1998) 1.59
Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma. J Exp Med (2008) 1.59
Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion. Reg Immunol (1993) 1.56
Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood (2007) 1.52
Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cell Signal (2009) 1.40
Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol (2011) 1.29
Insights into the initiation of type 2 immune responses. Immunology (2011) 1.25
Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol Pathol (2007) 1.24
Interleukin-33 and the function of innate lymphoid cells. Trends Immunol (2012) 1.20
Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection. J Immunol (2012) 1.14
Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry. Clin Exp Immunol (2000) 1.13
Interleukin-5 and IL-5 receptor in health and diseases. Proc Jpn Acad Ser B Phys Biol Sci (2011) 1.00
Interleukin 5 is protective during sepsis in an eosinophil-independent manner. Am J Respir Crit Care Med (2012) 1.00
A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation. Eur J Immunol (2011) 0.92
Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza A in the Tokyo area. Microbiol Immunol (2011) 0.89
Acute, but not resolved, influenza A infection enhances susceptibility to house dust mite-induced allergic disease. J Immunol (2009) 0.87
Using the one-lung method to link p38 to pro-inflammatory gene expression during overventilation in C57BL/6 and BALB/c mice. PLoS One (2012) 0.86
Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med (2009) 4.22
Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity (2003) 3.49
Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One (2009) 2.70
Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol (2004) 2.50
Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J Exp Med (2010) 2.22
Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol (2005) 2.13
Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med (2002) 2.12
Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest (2005) 2.07
Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J Immunol Methods (2007) 2.04
Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity (2005) 1.99
Differential response of respiratory dendritic cell subsets to influenza virus infection. J Virol (2008) 1.85
Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J Biol Chem (2012) 1.75
CD4+ T cell help and innate-derived IL-27 induce Blimp-1-dependent IL-10 production by antiviral CTLs. Nat Immunol (2011) 1.75
Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med (2010) 1.61
Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection. J Infect Dis (2006) 1.46
A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost. Vaccine (2006) 1.43
Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology (2012) 1.36
Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. J Virol (2004) 1.34
The role of macrophage polarization in infectious and inflammatory diseases. Mol Cells (2014) 1.28
Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. J Immunol (2008) 1.27
Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem (2004) 1.25
Sequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection. J Immunol (2007) 1.23
Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state. J Immunol (2010) 1.22
Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway. J Biol Chem (2011) 1.22
HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production. J Leukoc Biol (2007) 1.17
Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol (2005) 1.16
Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV. J Virol (2004) 1.15
gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol (2005) 1.15
Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology (2009) 1.15
Host and viral factors in the immunopathogenesis of primary hepatitis C virus infection. Immunol Cell Biol (2006) 1.14
Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function. J Immunol (2005) 1.13
Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog (2011) 1.12
HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1. Virology (2003) 1.10
RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology (2002) 1.06
Myeloid-derived suppressor cells: the dark knight or the joker in viral infections? Immunol Rev (2013) 1.05
Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol (2002) 1.05
LFA-1 is required for retention of effector CD8 T cells in mouse lungs. Blood (2003) 1.04
The cell cycle time of CD8+ T cells responding in vivo is controlled by the type of antigenic stimulus. PLoS One (2010) 1.03
Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS One (2012) 1.01
Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol (2013) 1.01
HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta. PLoS One (2010) 1.01
T cell responses during influenza infection: getting and keeping control. Trends Immunol (2011) 1.00
Proliferative expansion and acquisition of effector activity by memory CD4+ T cells in the lungs following pulmonary virus infection. J Immunol (2008) 0.99
Role of T cell immunity in recovery from influenza virus infection. Curr Opin Virol (2013) 0.98
Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection. J Immunol (2004) 0.96
Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes. Hepatology (2013) 0.95
Role of complement in immune regulation and its exploitation by virus. Viral Immunol (2007) 0.95
Retracted SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. J Virol (2005) 0.94
Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease. Viral Immunol (2009) 0.93
Regulation of NK cell repertoire and function in the liver. Crit Rev Immunol (2011) 0.93
Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection. J Virol (2013) 0.92
LAPCs promote follicular helper T cell differentiation of Ag-primed CD4+ T cells during respiratory virus infection. J Exp Med (2012) 0.91
Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation. J Leukoc Biol (2005) 0.89
Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex. J Biol Chem (2014) 0.88
Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage. J Immunol (2006) 0.88
Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells. J Virol (2011) 0.88
Stimulation of naive CD8+ T cells by a variant viral epitope induces activation and enhanced apoptosis. J Immunol (2010) 0.88
Sensitive detection and quantitation of mouse eosinophils in tissues using an enzymatic eosinophil peroxidase assay: its use to rapidly measure pulmonary eosinophilia during experimental respiratory syncytial virus infection of mice. J Immunol Methods (2002) 0.86
The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization. Virology (2003) 0.86
The molecular basis of HCV-mediated immune dysregulation. Clin Immunol (2004) 0.86
Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice. Hepatology (2014) 0.86
Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system. PLoS One (2009) 0.86
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003. Virus Res (2004) 0.85
The adaptive immune response to respiratory syncytial virus. Curr Top Microbiol Immunol (2013) 0.83
Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection. Clin Immunol (2009) 0.83
Recent insights into pulmonary repair following virus-induced inflammation of the respiratory tract. Curr Opin Virol (2012) 0.82
Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-mediated Hepatic Antiviral Immunity. Mol Ther Nucleic Acids (2013) 0.82
RSV 2007: recent advances in respiratory syncytial virus research. Viral Immunol (2008) 0.81
Retracted gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection. Virology (2005) 0.79
The effector T cell response to influenza infection. Curr Top Microbiol Immunol (2015) 0.79
Immunity to viruses. Immunol Rev (2013) 0.78
Stress-associated erythropoiesis initiation is regulated by type 1 conventional dendritic cells. J Clin Invest (2015) 0.77
The strange and critical intersection of hepatitis C and lipoprotein metabolism: "C-zing" the oil. Hepatology (2012) 0.77
Site-specific fatty acid-conjugation to prolong protein half-life in vivo. J Control Release (2013) 0.77
Not all effector CD8+ T cells are alike. Microbes Infect (2003) 0.77
Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation. J Clin Invest (2016) 0.77
Functional characterization of core genes from patients with acute hepatitis C virus infection. J Infect Dis (2010) 0.76
SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function. J Virol (2006) 0.75